Applied Genetic Technologies (AGTC) EBITDA (2014 - 2022)
Applied Genetic Technologies (AGTC) EBITDA from Mar 31, 2014 to Sep 30, 2022. The TTM Applied Genetic Technologies (AGTC) EBITDA is -$66M. You can adjust inflation or export chart.
Annual EBITDA
Quarterly EBITDA
Applied Genetic Technologies (AGTC) EBITDA CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +12.99% |
| 3 Years TTM | +60.94% |
| 5 Years TTM | +97.23% |
| All Time TTM | +16.81% |
Annual EBITDA change of Applied Genetic Technologies (AGTC)
| Year | EBITDA | Change |
|---|---|---|
| 2022 | -$65M | +13.46% |
| 2021 | -$57M | +24.95% |
| 2020 | -$46M | +1380.84% |
| 2019 | -$3.08M | -85.48% |
| 2018 | -$21M | -854.80% |
| 2017 | $2.81M | -284.87% |
| 2016 | -$1.52M | -93.71% |
| 2015 | -$24M | +97.71% |
| 2014 | -$12M | N/A |